Saludos
Teledoctor
CTC-chip Identifies Circulating Tumor Cells in Cancer Patients: "
Shannon Stott and colleagues at Massachusetts General Hospital Center for Engineering in Medicine have been developing a device that can accurately count and characterize rare circulating tumor cells (CTC) within blood. The technology in the CTC-chip already seems precise enough to identify the presence of localized or metastatic prostate cancer in real patients.
The MGH team used the automated system to analyze CTCs from two groups of prostate cancer patients. After the cells were initially captured on the CTC-chip, which is covered with microscopic posts coated with antibody to a common tumor protein, the cells were tagged using an antibody to prostate-specific antigen, allowing rapid scanning and more comprehensive visualization of the CTCs. Samples taken from a group of men with localized prostate cancer right before and at several intervals after surgical removal showed that, while CTCs disappeared immediately after surgery in some patients, CTC levels dropped only modestly in others. Analyzing CTCs from a group of patients being treated for metastatic prostate cancer revealed that, among patients whose tumors were responding to treatment, only a few CTCs displayed a marker found on proliferating cells. But in patients whose tumors were not responding, the majority of CTCs displayed the proliferation marker.'Further studies are needed to determine whether the differences seen in our study actually reflect which tumors are more invasive, in the case of the persistance/disappearance observation, or reveal important biological properties of the tumor,' says Stott, who is a research fellow in Surgery at Harvard Medical School. 'We are also working to create a 'plug-and-play' version of the machine that will be easy to use clinically, exploring options for large-scale production of the CTC-chip, and continuing to optimize the device to increase its speed and efficiency.'
More from MGH: Improved device provides more rapid, comprehensive analysis of circulating tumor cells...
Abstract in Science Translational Medicine : Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer
Saludos
Teledoctor
Entradas
